Cargando…

High-Content Screening of Eukaryotic Kinase Inhibitors Identify CHK2 Inhibitor Activity Against Mycobacterium tuberculosis

A screen of a eukaryotic kinase inhibitor library in an established intracellular infection model identified a set of drug candidates enabling intracellular killing of Mycobacterium tuberculosis (M.tb). Screen validity was confirmed internally by a Z′ = 0.5 and externally by detecting previously rep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shapira, Tirosh, Rankine-Wilson, Leah, Chao, Joseph D., Pichler, Virginia, Rens, Celine, Pfeifer, Tom, Av-Gay, Yossef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530171/ https://www.ncbi.nlm.nih.gov/pubmed/33042061 http://dx.doi.org/10.3389/fmicb.2020.553962

Ejemplares similares

From infection niche to therapeutic target: the intracellular lifestyle of Mycobacterium tuberculosis
por: Rankine-Wilson, Leah Isobella, et al.
Publicado: (2021)

DMN-Tre Labeling for Detection and High-Content Screening of Compounds against Intracellular Mycobacteria
por: Sahile, Henok A., et al.
Publicado: (2020)

Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication
por: Shapira, Tirosh, et al.
Publicado: (2022)

Chk-mate on resistance to kinase inhibitors
por: Shapiro, Paul
Publicado: (2018)

Keeping RelApse in Chk: molecular mechanisms of Chk1 inhibitor resistance in lymphoma
por: Black, Elizabeth M., et al.
Publicado: (2022)

Disruption of the serine/threonine protein kinase H affects phthiocerol dimycocerosates synthesis in Mycobacterium tuberculosis
por: Gómez-Velasco, Anaximandro, et al.
Publicado: (2013)

Tumour growth environment modulates Chk1 signalling pathways and Chk1 inhibitor sensitivity
por: Massey, Andrew J.
Publicado: (2016)

Protein tyrosine kinase, PtkA, is required for Mycobacterium tuberculosis growth in macrophages
por: Wong, Dennis, et al.
Publicado: (2018)

Mycobacterium tuberculosis Nucleoside Diphosphate Kinase Inactivates Small GTPases Leading to Evasion of Innate Immunity
por: Sun, Jim, et al.
Publicado: (2013)

Dominant mutations in CHK1 cause pronuclear fusion failure and zygote arrest that can be rescued by CHK1 inhibitor
por: Zhang, Honghui, et al.
Publicado: (2021)

BRD7 suppresses tumor chemosensitivity to CHK1 inhibitors by inhibiting USP1-mediated deubiquitination of CHK1
por: Li, Lemin, et al.
Publicado: (2023)

Inositol monophosphate phosphatase genes of Mycobacterium tuberculosis
por: Movahedzadeh, Farahnaz, et al.
Publicado: (2010)

Crystal Structures of Two Aminoglycoside Kinases Bound with a Eukaryotic Protein Kinase Inhibitor
por: Fong, Desiree H., et al.
Publicado: (2011)

Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine
por: Advani, Gahana, et al.
Publicado: (2017)

γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments
por: Rawlinson, Rebecca, et al.
Publicado: (2014)

Resistance to the CHK1 inhibitor prexasertib involves functionally distinct CHK1 activities in BRCA wild-type ovarian cancer
por: Nair, Jayakumar, et al.
Publicado: (2020)

MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells
por: Bridges, Kathleen A., et al.
Publicado: (2016)

Efficient Synthesis of Benzothiazinone Analogues with Activity against Intracellular Mycobacterium tuberculosis
por: Richter, Adrian, et al.
Publicado: (2021)

The Role of Wild-Type p53 in Cisplatin-Induced Chk2 Phosphorylation and the Inhibition of Platinum Resistance with a Chk2 Inhibitor
por: Liang, Xiaobing, et al.
Publicado: (2011)

Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia
por: Rorà, Andrea Ghelli Luserna Di, et al.
Publicado: (2016)

Ubiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation
por: Yu, Xinfang, et al.
Publicado: (2020)

Benzimidazole inhibitors of the protein kinase CHK2: Clarification of the binding mode by flexible side chain docking and protein–ligand crystallography
por: Matijssen, Cornelis, et al.
Publicado: (2012)

CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin
por: Di Franco, Simone, et al.
Publicado: (2021)

Small molecule inhibitors and a kinase-dead expressing mouse model demonstrate that the kinase activity of Chk1 is essential for mouse embryos and cancer cells
por: Muralidharan, Somsundar V, et al.
Publicado: (2020)

Chk1, Chk2, is the amplifier on?
por: Dove, Alan W.
Publicado: (2001)

CHK2 kinase in the DNA damage response and beyond
por: Zannini, Laura, et al.
Publicado: (2014)

A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors
por: Xiao, Ting, et al.
Publicado: (2016)

Selective Mycobacterium tuberculosis Shikimate Kinase Inhibitors as Potential Antibacterials
por: Gordon, Sara, et al.
Publicado: (2015)

Structure-Guided Evolution of Potent and Selective CHK1 Inhibitors through Scaffold Morphing
por: Reader, John C., et al.
Publicado: (2011)

Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine
por: Goss, Kelli L, et al.
Publicado: (2017)

Inactivation of PRIM1 Function Sensitizes Cancer Cells to ATR and CHK1 Inhibitors()
por: Job, Albert, et al.
Publicado: (2018)

MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity
por: Branigan, Timothy B., et al.
Publicado: (2021)

A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors
por: Di Giulio, Stefano, et al.
Publicado: (2021)

The Combination of ATM and Chk1 Inhibitors Induces Synthetic Lethality in Colorectal Cancer Cells
por: Tozaki, Yuri, et al.
Publicado: (2023)

Derivation of Naïve Human Embryonic Stem Cells Using a CHK1 Inhibitor
por: Ware, Carol B., et al.
Publicado: (2023)

Genome Sequences of the Mycobacterium tuberculosis H37Rv-ptkA Deletion Mutant and Its Parental Strain
por: Tsui, Clement K. M., et al.
Publicado: (2017)

BCG immunomodulation: From the ‘hygiene hypothesis’ to COVID-19
por: Moulson, Aaron J., et al.
Publicado: (2021)

Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis
por: Mikawa, Takumi, et al.
Publicado: (2020)

AR phosphorylation and CHK2 kinase activity regulates IR-stabilized AR–CHK2 interaction and prostate cancer survival
por: Ta, Huy Q, et al.
Publicado: (2020)

Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells
por: Kim, Marianne K, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n3mbp7gkv3kstnds5n98gp6ecf